Current recommendations of full renin-angiotensin system blockade 9, intensive insulin therapy, and stringent lipid and blood pressure control 10-12 mainly focus on mitigating the symptoms and retarding the progression to DN, but lack efficacy 13, with the residual risk of developing DN ranging between 46% to 84% 10,14. Here, INS is linked to liver dysplastic nodule.